Rik Joos

Oral apremilast in the treatment of active psoriatic arthritis: Results of a multicenter, randomized, double‐blind, placebo‐controlled study

Georg Schett, J. Wollenhaupt, Kim Papp et al. · Arthritis & Rheumatism · 2012 · 204 citations

Medicine, Clinical Sciences, Pharmacotherapy +12

Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial

Patrick Verschueren, Diederik De Cock, Luk Corluy et al. · Annals of the Rheumatic Diseases · 2014 · 129 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Favourable outcome in 135 children with juvenile systemic sclerosis: results of a multi‐national survey

Ivan Foeldvari, M. Zhavania, Nina Birdi et al. · Lara D. Veeken · 2000 · 124 citations

Medicine, Child Health, Pediatrics +3

Effectiveness of methotrexate with step-down glucocorticoid remission induction (COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis in a treat-to-target approach: 1-year results of CareRA, a randomised pragmatic open-label superiority trial

Patrick Verschueren, Diederik De Cock, Luk Corluy et al. · Annals of the Rheumatic Diseases · 2016 · 114 citations

Medicine, Clinical Sciences, Pharmacotherapy +16

Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial

Anna Moltó, Clementina López‐Medina, Filip Van den Bosch et al. · Annals of the Rheumatic Diseases · 2021 · 103 citations · Full text

Medicine, Pharmacotherapy, Musculoskeletal Medicine +14